Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production

Journal of Leukocyte Biology

Volumn 59, Issue 2, 1996, Pages 219-228

  Pinckard, R Neal ^a,b   Prihoda, Thomas J ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

acyl PAF; alkyl PAF; PAF receptors; PMN priming; Superoxide anion; WEB 2086

Indexed keywords

ACYL THROMBOCYTE ACTIVATING FACTOR; ALKYL THROMBOCYTE ACTIVATING FACTOR; APAFANT; FORMYLPEPTIDE; RECOMBINANT COMPLEMENT COMPONENT C5A; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

EID: 9044244909     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.59.2.219     Document Type: Article

References (36)

1. Venable, M.E., Zimmerman, G.A., McIntyre, T.M., Prescott, S.M. (1993) Platelet-activating factor: a phospholipid autacoid with diverse actions. J. Lipid Res. 34, 691-702.
2. McManus, L.M., Woodard, D.S., Deavers, S.I., Pinckard, R.N. (1993) Biology of disease. PAF molecular heterogeneity: pathobiological implications. Lab. Invest. 69, 639-650.
3. Pinckard, R.N., Woodard, D.S., Showell, H.J., Conklyn, M.J., Novak, M.J., McManus, L.M. (1994) Structural and (patho)physiological diversity of PAF. Clin. Rev. Allergy 12, 329-359.
4. Pinckard, R.N., Showell, H.J., Castillo, R., Lear, C., Breslow, R., McManus, L.M., Woodard, D.S., Ludwig, J.C. (1992) Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl-analogs of platelet-activating factor (PAF). J. Immunol. 148, 3528-3535.
5. Casals-Stenzel, J., Muacevic, G., Weber, K.H. (1987) Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J. Pharmacol. Exp. Ther. 241, 974-981.
6. Itaya, K., Ui, M. (1966) A new micromethod for the colorimetric determination of inorganic phosphate. Clin. Chim. Acta 14, 361-366.
7. Weintraub, S.T., Ludwig, J.C., Molt, G.E., McManus, L.M., Pinckard, R.N. (1985) Fast atom bombardment-mass spectrometric identification of molecular species of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 129, 868-876.
8. Weintraub, S.T., Lear, C., Pinckard, R.N. (1993) Differential electron capture mass spectral response of pentafluorobenzoyl derivatives of platelet activating factor alkyl chain homologs. Biol. Mass Spectrum. 22, 559-564.
9. Shaw, J.O., Pinckard, R.N., Ferrigni, K.S., McManus, L.M., Hanahan, D.J. (1981) Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor). J. Immunol. 127, 1250-1255.
10. Gay, J.C. (1993) Mechanism and regulation of neutrophil priming by platelet-activating factor. J. Cell. Physiol. 156, 189-197.
11. 4 in human neutrophils. Pharmacol. Res. Comm. 18(Suppl.), 51-59.
12. Suzuki, S., Sugai, K., Sato, H., Arakawa, M. (1994) Effect of a platelet-activating factor antagonist, WEB 2086, on inhibition of active oxygen generation in human polymorphonuclear leukocytes. Pharmacology 48, 111-118.
13. Valone, F.H., Goetzl, E.J. (1983) Specific binding by human polymorphonuclear leukocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphoryl choline. Immunology 48, 141-149.
14. O'Flaherty, J.T., Suilles, J.R., Redman, J., Jacobson, D., Piantadosi, C., Wykle, R.L. (1986) Binding and metabolism of platelet-activating factor by human neutrophils. J. Clin. Invest. 78, 381-388.
15. O'Flaherty, J.T., Jacobson, D.P., Redman, J.F. (1992) Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils. Biochem. J. 288, 241-248.
16. Svetlov, S., Nigam, S. (1993) Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils. Biochem. Biophys. Res. Commun. 190, 162-166.
17. 3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes. J. Lipid Med. 7, 57-78.
18. Kunz, D., Gerard, N.P., Gerard, C. (1992) The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J. Biol. Chem. 267, 9101-9106.
19. Ali, H., Richardson, R.M., Tomhave, E.D., DuBose, R.A., Haribabu, B., Snyderman, R. (1994) Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. J. Biol. Chem. 269, 24557-24563.
20. Gay, J.C., Beckman, J.K., Zaboy, K.A., Lukens, J.N. (1986) Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. Blood 67, 931-936.
21. Van Epps, D.E., Simpson, S., Bender, J.G., Chenoweth, D.E. (1990) Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J. Immunol. 144, 1062-1068.
22. Norgauer, J., Eberle, M., Fay, S.P., Lemke, H.D., Sklar, L.A. (1991) Kinetics of N-formyl peptide receptor up-regulation during stimulation in human neutrophils. J. Immunol. 146, 975-980.
23. Fearon, D.T., Collins, L.A. (1983) Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J. Immunol. 130, 370-375.
24. Van Epps, D.E., Simpson, S.J., Johnson, R. (1993) Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a. J. Immunol. 150, 246-252.
25. Koenderman, L., Yazdanbakhsh, M., Roos, D., Vethoeven, A.J. (1989) Dual mechanisms in priming of the chemoattractant-induced respiratory burst in human granulocytes. J. Immunol. 142, 623-628.
26. Dent, G., Ukena, D., Chanez, P., Sybrecht, G., Barnes, P. (1989) Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. FEBS Lett. 244, 365-368.
27. Pinckaid, R.N., Ludwig, J.C., McManus, L.M. (1988) Platelet-activating factors. In Inflammation: Basic Principles and Clinical Correlates (J.I. Gallin, I.M. Goldstein, and R. Snyderman, eds) Raven Press, New York, 139-167.
28. Triggiani, M., Goldman, D.W., Chilton, F.H. (1991) Biological effects of 1-ac)1-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. Biochim. Biophys. Acta 1084, 41-47.
29. O'Flaherty, J.T., Tessner, T., Greene, D., Redman, J.R., Wykle, R.L. (1994) Comparison of 1-O-alkyl-, 1-O-alk-1′-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. Biochim. Biophys. Acta 1210, 209-216.
30. Triggiani, M., Schleimer, R.P., Warner, J.A., Chilton, F.H. (1991) Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J. Immunol. 147, 660-666.
31. 3H]acetyl-sn-glycero-3-phosphocholine, a structural analog of platelet activating factor, by vascular endothelial cells. Biochem. Biophys. Res. Commun. 176, 1557-1564.
32. Clay, K.L., Johnson, C., Worthen, G.S. (1991) Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells. Biochim. Biophys. Acta 1094, 43-50.
33. Whatley, R.E., Clay, K.L., Chilton, F.H., Triggiani, M., Zimmerman, G.A , McIntyre, T.M., Prescott, S.M. (1992) Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. Prostaglandins 43, 21-29.
34. Lorant, D.E., Patel, K.D., McIntyre, T.M., McEver, R.P., Prescott, S.M., Zimmerman, G.A. (1991) Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115, 223-234.
35. Zimmerman, G.A., Lorant, D.E., McIntyre, T.M., Prescott, S.M. (1993) Juxtacrine intracellular signaling: another way to do it. Am. J. Respir. Cell Mol. Biol. 9, 573-577.
36. Lorant, D.E., Topham, M.K., Whatley, R.E., McEver, R.P., McIntyre, T.M., Prescott, S.M., Zimmerman, G.A. (1993) Inflammatory roles of P-selectin. J. Clin. Invest. 92, 559-570.